Efficacy/safety of entrectinib in patients (pts) with ROS1-positive (ROS1 +) advanced/metastatic NSCLC from the Blood First Assay Screening Trial (BFAST) için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Efficacy/safety of entrectinib in patients (pts) with ROS1-positive (ROS1 +) advanced/metastatic NSCLC from the Blood First Assay Screening Trial (BFAST) | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Ocak 2024 | 0 |
| Şubat 2024 | 0 |
| Mart 2024 | 0 |
| Nisan 2024 | 0 |
| Mayıs 2024 | 0 |
| Haziran 2024 | 0 |
| Temmuz 2024 | 0 |
